Cisplatin/Glutathione

顺铂/谷胱甘肽

Report date: 2022/03/10 17:50:52

Base Information

Drug NameCisplatin/Glutathione
Drug Alias Name谷胱甘肽/顺铂Glutathione and CisplatinCisplatin and GlutathioneGlutathione/CisplatinBAM-002
ClassificationSmall molecules
Mechanisms of ActionDNA synthesis inhibitorsImmunomodulatorsDNA cross linking agents
TargetsDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes CisplatinGlutathione
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesCellectar Biosciences Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01XY
Related LinksN/A